Vapotherm UK

Curious about the Oxygen Assist Module's performance in practical settings? The recent ROAM study, carried out in an active clinical environment, demonstrated that the Vapotherm Oxygen Assist Module significantly reduces the occurrence of severe hypoxaemia and severe hyperoxaemia compared to manual control. https://hubs.ly/Q02Fc_sT0

Seats are filling up fast for our upcoming live webinar - Why Cannula Design Matters! Get involved in the discussion on how cannula design can support your patient therapy, book your spot today! #HYPERACT https://hubs.ly/Q02DGGyH0

“The thing I like about having the nasal cannula is that a parent can see their child's face.” Hear from Karen about the positive impact #HighVelocityTherapy can have on a child and their parents when it comes to comfort and interaction. Discover HVT 2.0 today! https://hubs.ly/Q02DnvLc0

The hot topic of #HYPERACT continues with the discussion of cannula design and why it matters. Have you booked your spot yet? https://hubs.ly/Q02DGD_j0

A recent study, discussing pre-term delivery stabilisation - https://hubs.ly/Q02DGBtj0 identifed potential risks of mask-based stabilisation - what is your approach in the delivery room? Learn how high velocity therapy can provide a gentler alternative to nCPAP for primary respiratory support in neonates. https://hubs.ly/Q02DGwmw0

"Design is not just what it looks like and feels like. Design is how it works." - Steve Jobs. In this live webinar, a panel of clincians and engineers discuss how the internal diameter of a cannula affects patient therapy! Save your seat to find out why cannula design matters! #HYPERACT https://hubs.ly/Q02DpQ-P0

Extended stays in critical care can significantly affect both patients and their families, causing lasting physical and psychological issues like PTSD, muscle atrophy, fatigue, and anxiety. Research indicates that green spaces in hospital environments can greatly alleviate anxiety and stress, serving as a natural aid for recovery and enhancing mental health. At Vapotherm, we share your commitment to patient care, and our innovative HVT 2.0 device is designed with mobility in mind. Learn how the HVT 2.0 can assist in supporting your patients! https://hubs.ly/Q02z3pCM0

Authors, Scott Leonard and Robert Kacinski, used Computational Fluid Dynamics (CFD) to compare the flush of the upper airway using a small-bore high velocity nasal cannula to that of a large-bore high flow nasal cannula in different scenarios to simulate an adult patient in respiratory distress. In all scenarios, the high velocity nasal cannula was able to more effectively reduce the carbon dioxide (CO2) levels in the upper airway by the end of exhalation than high flow nasal cannula. Specific to the open mouth model, there was less than half the CO2 at the end of exhalation with the high velocity nasal cannula than there was with the high flow nasal cannula. First author, Robert Kacinski, reviews a plotted graph of the cumulative CO2 in the upper airway with 1. No Therapy 2. High Flow Therapy and 3. High Velocity Therapy.

HVT 2.0 distinguishes itself by offering a dependable solution for patient therapy during transportation. With its integrated battery backup, it guarantees that therapy sessions proceed without interruption, providing a smooth and continuous experience for patients and clinicians alike. Request A Demo https://hubs.ly/Q02z3pPT0

Do you have a lightbulb moment for using high velocity therapy for hypercapnic patients? Comment below. If you haven’t yet, have you seen the #HYPERACT data yet? Thank you, Dr. Yamane for sharing your ah-ha moment! #HighVelocityTherapy #Hypercapnia